Successful Treatment of a Prosthetic Joint Infection due to Mycobacterium abscessus
Author(s) -
Andrew Petrosoniak,
Paul J. Kim,
Marc Desjardins,
B. Craig Lee
Publication year - 2009
Publication title -
canadian journal of infectious diseases and medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 38
eISSN - 1918-1493
pISSN - 1712-9532
DOI - 10.1155/2009/968052
Subject(s) - mycobacterium abscessus , clarithromycin , cefoxitin , amikacin , medicine , joint arthroplasty , surgery , arthroplasty , mycobacterium , antibiotics , microbiology and biotechnology , biology , pathology , bacteria , staphylococcus aureus , tuberculosis , genetics , helicobacter pylori
Prosthetic joint infection due to Mycobacterium abscessus is uncommon and optimal therapy remains poorly defined. Following a two-stage revision, clinical and microbiological cure was achieved in a patient with a M abscessus-infected total hip arthroplasty. A prolonged course of directed antibacterial therapy comprising clarithromycin and cefoxitin coupled with the application of amikacin-impregnated cement likely contributed to the successful outcome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom